Medpace

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. 

CEO
August James Troendle
CEOAugust James Troendle
Employees
5,900
Employees5,900
Headquarters
Cincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded
1992
Founded1992
Employees
5,900
Employees5,900

MEDP Key Statistics

Market cap
18.68B
Market cap18.68B
Price-Earnings ratio
41.73
Price-Earnings ratio41.73
Dividend yield
Dividend yield
Average volume
378.52K
Average volume378.52K
High today
$609.45
High today$609.45
Low today
$590.10
Low today$590.10
Open price
$603.05
Open price$603.05
Volume
146.91K
Volume146.91K
52 Week high
$625.00
52 Week high$625.00
52 Week low
$250.05
52 Week low$250.05

MEDP News

Benzinga 4h
Medpace Analysts Increase Their Forecasts After Upbeat Q3 Earnings

Medpace Holdings Inc. (NASDAQ:MEDP) posted better-than-expected third-quarter earnings on Thursday. The clinical contract research organization reported earnin...

Medpace Analysts Increase Their Forecasts After Upbeat Q3 Earnings
TipRanks 8h
Medpace price target raised to $485 from $425 at Barclays

Barclays analyst Luke Sergott raised the firm’s price target on Medpace (MEDP) to $485 from $425 and keeps an Underweight rating on the shares following the ear...

TipRanks 13h
Medpace Holdings Reports Strong Q3 2025 Results

Medpace Holdings Inc ( (MEDP) ) has released its Q3 earnings. Here is a breakdown of the information Medpace Holdings Inc presented to its investors. Elevate Y...

Analyst ratings

57%

of 14 ratings
Buy
7.1%
Hold
57.1%
Sell
35.7%

More MEDP News

TipRanks 18h
Medpace Holdings: Overvaluation Concerns Amid Growth Projections and Market Positioning

TD Cowen analyst Charles Rhyee has maintained their bearish stance on MEDP stock, giving a Sell rating today. Elevate Your Investing Strategy: Take advantage of...

Benzinga 1d
Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins

Medpace Holdings Inc. (NASDAQ:MEDP) is trading higher on Thursday after the company released third-quarter earnings. The clinical contract research organizatio...

Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins
Simply Wall St 1d
Is Medpace Still Attractive After a 65.6% Surge and New Digital Health Partnership?

Thinking about Medpace Holdings and wondering if there is still room for your investment dollar? You are not alone. Over the past year, Medpace has been quite t...

Is Medpace Still Attractive After a 65.6% Surge and New Digital Health Partnership?
Investor's Business Daily 2d
Medpace Rockets On 'Another Strong Q' That Includes A Guidance Hike

Medpace stock rocketed late Wednesday on "another strong Q," that included double-digit sales and profit growth and a guidance hike. "There's no other term of...

Medpace Rockets On 'Another Strong Q' That Includes A Guidance Hike
Simply Wall St 6d
Medpace Holdings Valuation: Assessing Fair Value After Raised Outlook and Share Buybacks

Medpace Holdings (MEDP) turned heads this quarter with organic revenue growth in the mid-teens and a 20% jump in operating earnings. Management also bought back...

Medpace Holdings Valuation: Assessing Fair Value After Raised Outlook and Share Buybacks

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.